One-year Outcomes of Lung Transplantation for COVID-19 Associated End Stage Lung Disease in the United States.

Kenji Okumura Soma S K Jyothula Thomas Kaleekal Abhay Dhand

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)

Lung transplantation offers a safe and effective option for carefully selected patients with end-stage lung disease from prior COVID-19, with short-term and long-term outcomes similar to lung transplant recipients of non-COVID etiology.

Keyphrases

coronavirus disease
sars cov
extracorporeal membrane oxygenation
respiratory syndrome coronavirus
type diabetes
adipose tissue
skeletal muscle
weight loss